Form 4 holding
Chief Medical Officer, Head of Research & Development
Nkarta, Inc.
- Security class
- Common Stock
- Shares / value
- 70,000
- Estimated value
- $134,169
- Report date
- 06 Jan 2026
- Price
- $1.92
- Ownership
- Direct
Shawn Marshall Rose
Insider Reports History
- Reporting-owner location
- Princeton Junction, NJ
- Latest reporting-owner signature
-
/s/ Bridgette Housley, as Attorney-in-Fact
Source: Latest parsed Forms 3/4/5 signature
- Transaction source note
- Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.
Identity
Names, identifiers, and filing context for this profile.
1 identity field
SEC source record
Original filing metadata and source links for verification.
1 source field
Source evidence
Original filing metadata and source links for verification.
1 source field
Reported holdings for Shawn Marshall Rose
Form 4 holding
Chief Medical Officer, Head of Research & Development
Nkarta, Inc.
- Security class
- Stock Option (right to buy)
- Shares / value
- 139,000
- Estimated value
- Report date
- 06 Jan 2026
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Insider Reports Filed by Shawn Marshall Rose
4
NKTX
Nkarta, Inc.
- Report period
- 06 Jan 2026
- Transactions
- 2
- Transaction value
- $0
- Accepted by SEC
- 08 Jan 2026, 17:50
- Role
- Chief Medical Officer, Head of Research & Development
- Next action
- Open filing details
4
NKTX
Nkarta, Inc.
- Report period
- 23 Jun 2025
- Transactions
- 1
- Transaction value
- $0
- Accepted by SEC
- 25 Jun 2025, 16:00
- Role
- Chief Medical Officer, Head of Research & Development
- Next action
- Open filing details
3
NKTX
Nkarta, Inc.
- Report period
- 23 Jun 2025
- Transactions
- 0
- Transaction value
- $0
- Accepted by SEC
- 25 Jun 2025, 16:00
- Role
- Chief Medical Officer, Head of Research & Development, Exhibit List: Exhibit 24 - Power of Attorney
- Next action
- Open filing details